School of Life Sciences

Fosters education, research and innovation at the interface of engineering and biology to advance the understanding of the living world and solve biomedical problems.

scientists from the group led by Matthias Lütolf at EPFL's Institute of Bioengineering have found a way to “guide” stem cells to form an intestinal organoid that looks and functions just like a real tissue. © EPFL – Mikhail Nikolaev – Lütolf lab

Our Mission

EPFL students working on portable biosensor

Education

We train engineers in Life Sciences with a solid polytechnic foundation. Our students acquire a multi-disciplinary education and study biology jointly with engineering, basic and computer sciences. We offer a Bachelor and Master program in Life Sciences Engineering, as well as four Doctoral programs in biotechnology and bioengineering, computational and quantitative biology, molecular life sciences and neurosciences.

Research

Our research groups operate at the interface of biology, basic sciences, computer sciences and engineering. This interdisciplinary environment stimulates innovative research to address essential questions in biological sciences. Cutting-edge core facilities and infrastructure support our scientists to push the boundaries of knowledge in development, neurosciences, immunology, cancer, infectious diseases and bioengineering.

Prosthetic hand feels objects

Innovation

We cultivate a climate of exploration and translation of knowledge and technologies to a sustainable benefit of humankind. The life sciences flagship innovation encouragement program, Catalyze4Life, facilitates the advancement of scientific know-how towards applications. We maintain a constructive and open dialogue between science, industry and society.

Next-gen organoids grow and function like real tissues

watch

Bioengineers at EPFL have created miniature intestines in a dish that match up anatomically and functionally to the real thing better than any other lab-grown tissue models. The biological complexity and longevity of the new organoid technology is an important step towards enabling drug testing, personalized medicine, and perhaps, one day, transplantations.

Key Numbers

1,094

Bachelor, Master and PhD students

52

Research groups

40+

Companies founded